Por: The Hill Health December 15, 2022
Researchers found the combination of Moderna’s mRNA vaccine and Merck’s Keytruda in melanoma patients reduced the risk of death or relapse of the disease by 44 percent compared to patients just taking Keytruda. The results are the first time that an mRNA vaccine, which uses the same technology as Moderna and Pfizer’s COVID-19 vaccines, demonstrated an increased immune response in a patient when combined with a drug they are taking. . ... + full article
The Hill USA Health December 15, 2022
RIP to Mike Leach, a pioneering college football coach who evening following complications from a heart condition. Today in health, lawmakers told Pfizer’s CEO to “back off” from raising the price of the company’s COVID-19 vaccine. and . Someone forward you... + más
Octopus venom found to slow the growth of cancer | Newsweek
Khloé Kardashian’s cancerous face tumor scare: How ‘incredibly rare’ is it? | New York Post
Time USA Health December 13, 2022
Coming off the success of its mRNA vaccine for COVID-19, Moderna announced on Dec. 13 that it achieved encouraging results when it turned its vaccine technology against cancer. The company reported in a that among 157 people with stage 3 or stage 4 melanoma, a personalized... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
ABC7 USA Health October 18, 2022
in an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available before 2030.The husband-and-wife duo founded BioNTech in 2008 originally to develop... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe
ABC News USA World October 18, 2022
LONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine.We feel that a cure for cancer or to changing cancer patients' lives is in our grasp, professor Ozlem Tureci told in an interview... + más
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
About iurex | Privacy Policy | Disclaimer |